OCC 1.25% 39.5¢ orthocell limited

Ann: Successful OrthoATI clinical trial, page-38

  1. 2,336 Posts.
    lightbulb Created with Sketch. 448
    Regardless of todays muted response, I’m a happier shareholder today than I was yesterday. Really looking forward to seeing what we can achieve over the coming years.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.